Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2009-01-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy
NCT01228981
Diabetic Retinopathy and Visual Function Study
NCT00001346
Blood Factors and Diabetic Retinopathy
NCT00005761
Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
NCT01229540
Severe Proliferative Diabetic Retinopathy
NCT01115257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Macular Edema (ME) development during the study period, mainly Clinically Significant ME (CSME) needing treatment, will be the primary indicator for DR progression. CSME will be considered as the primary end-point and will be used to identify phenotypes (and risk markers) of DR progression.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DR
Type-2 diabetic subjects diagnosed with diabetic retinopathy (DR).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females or Males;
* Age over 18 years;
* Signed Informed Consent;
* Previous follow-up with regular systemic and ophthalmic assessments.
Exclusion Criteria
* Vitreous syneresis or posterior vitreous detachment;
* Dilatation of the pupil \< 5 mm.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association for Innovation and Biomedical Research on Light and Image
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José Cunha-Vaz, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Association for Innovation and Biomedical Research on Light and Image
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIBILI - Clinical Trial Center
Coimbra, Coimbra District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cunha-Vaz J. Characterization and relevance of different diabetic retinopathy phenotypes. Dev Ophthalmol. 2007;39:13-30. doi: 10.1159/000098497.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNTM018A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.